过去一年中添加的文章，按日期排序
[HTML][HTML] … of First-Line Osimertinib and Other EGFR-Tyrosine Kinase Inhibitors on Overall Survival in Untreated Advanced EGFR-Mutated Non-small Cell Lung Cancer …
M Hibino, Y Imamura, R Shimoyama, T Fukui, R Fukai… - Targeted Oncology, 2024 - Springer
1 天前 - … in the first-line treatment of EGFR-mutated advanced NSCLC, based on the results
of a … with osimertinib compared with those achieved through gefitinib or erlotinib treatment [4]…
of a … with osimertinib compared with those achieved through gefitinib or erlotinib treatment [4]…
[引用][C] SUCCESSFUL TREATMENT OF SWITCHING EGFR-TKI FOR ADVANCED LUNG ADENOCARCINOMA BECAUSE OF INTERSTITIAL LUNG DISEASE
X ZENG - CHEST, 2024 - journal.chestnet.org
4 天前 - … Compared with chemotherapy, EGFR-TKIs have their own … refused EGFR-TKIs
because of various side effects, … treatment of EGFR mutation NSCLC with almonertinib after …
because of various side effects, … treatment of EGFR mutation NSCLC with almonertinib after …
[HTML][HTML] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Cancer: Current Use and Future Prospects
H Dickerson, A Diab, O Al Musaimi - International Journal of Molecular …, 2024 - mdpi.com
4 天前 - … in patients with NSCLC compared to both erlotinib and … Phase III trials to compare
osimertinib and gefitinib as first-… of 237 advanced NSCLC patients with EGFR mutations: 160 …
osimertinib and gefitinib as first-… of 237 advanced NSCLC patients with EGFR mutations: 160 …
Meta-analysis of Targeted Therapies in EGFR-mutated Non–Small Cell Lung Cancer: Efficacy and Safety of Osimertinib, Erlotinib, and Gefitinib as First-line Treatment
10 天前 - … with EGFR-mutated advanced NSCLC. The meta-analysis outcomes have
demonstrated that osimertinib, erlotinib, or gefitinib positively impact … Comparison of gefitinib plus …
demonstrated that osimertinib, erlotinib, or gefitinib positively impact … Comparison of gefitinib plus …
[PDF][PDF] Disproportionality Analysis of Osimertinib-related Adverse Events in Elderly Patients Using the Japanese Pharmacovigilance Database
T Omoto, J Asaka, K Kudo - Cancer diagnosis …, 2024 - cancerdiagnosisprognosis.org
20 天前 - … inhibitors (EGFR-TKIs), such as gefitinib, erlotinib, and … (AEs) compared to the
first-generation EGFR-TKI group (34… patients with EGFR mutation-positive advanced NSCLC (8-10…
first-generation EGFR-TKI group (34… patients with EGFR mutation-positive advanced NSCLC (8-10…
[HTML][HTML] Erlotinib or Gefitinib for Treating Advanced Epidermal Growth Factor Receptor Mutation–Positive Lung Cancer in Aotearoa New Zealand: Protocol for a …
PS Aye, J Barnes, G Laking, L Cameron… - JMIR Research …, 2024 - researchprotocols.org
81 天前 - … ) for treating advanced lung cancer, but their impact in this … with advanced EGFR
mutation–positive lung cancer who … of treatment with erlotinib or gefitinib, the comparison of …
mutation–positive lung cancer who … of treatment with erlotinib or gefitinib, the comparison of …
[HTML][HTML] … pretreatment experience in patients with epidermal growth factor receptor T790M mutation-positive locally advanced or metastatic non-small cell lung cancer
128 天前 - … Studies examining EGFR mutation frequency revealed a … had received prior afatinib,
erlotinib and gefitinib were 11.2 (95… comparing PFS and OS between different initial EGFR-…
erlotinib and gefitinib were 11.2 (95… comparing PFS and OS between different initial EGFR-…
Efficacy and Adverse Events of Osimertinib Correlate With Blood Concentration of Osimertinib and Its Active Metabolites, AZ5104 and AZ7550
T Okuno, M Hongo, R Tanino, Y Tsubata… - … -EDGE LUNG CANCER …, 2024 - atsjournals.org
143 天前 - … , EGFR mutation-positive advanced NSCLC patients who received either osimertinib
or a standard EGFR-tyrosine kinase inhibitor [TKI], such as gefitinib … group compared to the …
or a standard EGFR-tyrosine kinase inhibitor [TKI], such as gefitinib … group compared to the …
[PDF][PDF] European Society of Medical Oncology (ESMO) guidelines for oncogene-addicted metastatic non-small cell lung cancer (NSCLC): a personalized treatment for …
G Suay, F Aparisi, O Juan-Vidal - Chinese Clinical Oncology, 2024 - cdn.amegroups.cn
214 天前 - … gefitinib and erlotinib in first-line setting. However, no direct comparison was done
against second generation EGFR … not been directly compared, and the side effects profile of …
against second generation EGFR … not been directly compared, and the side effects profile of …
[HTML][HTML] 113P The prognostic importance of nutrition and inflammation in advanced lung cancer with actionable mutation
D Bayram, B Bilgin, Ş Yücel - ESMO Open, 2024 - esmoopen.com
234 天前 - … the prognostic effect of pre-treatment PNI in advanced … of EGFR /ALK mutation,
receipt of erlotinib/gefitinib in EGFR … lower approximately 50% compared with PNI < 50 group. In …
receipt of erlotinib/gefitinib in EGFR … lower approximately 50% compared with PNI < 50 group. In …